Neelaysh Vukkadala

Dec 18, 2023 | opmed.doximity.com | Jordan Frey |Benjamin Wade Frush |Lynne Lederman |Neelaysh Vukkadala

3 Steps for Achieving Financial GoalsMost people agree that goals are important to have, as they help us get what we want. But then why is it that we, in general, are not great at identifying goals, working toward them, and reaching them? There are many reasons, but the two main ones are probably that we don’t spend enough time sitting with ourselves (and loved ones) thinking about what we actually want; and that we don’t record and measure our goals.

Dec 18, 2023 | opmed.doximity.com | Benjamin Wade Frush |Jordan Frey |Lynne Lederman |Neelaysh Vukkadala

Dear Intern, As you prepare to transition to supervising resident, I believe there are a few things you should consider, items you won’t find in any textbook, database, or lecture. You are probably already receiving counsel about the clinical and technical aspects of the job, which feel so imposing right now. However, the truth is, you will learn them; the system is fool-proof in ensuring that, by the sheer volume of your clinical experiences.

Dec 18, 2023 | opmed.doximity.com | Neelaysh Vukkadala |Lynne Lederman |Danielle Pigneri

As I turn the key in the ignition, the engine feebly tries to start, nearly catching and then fading three times. I have had this steel blue 2007 Volvo S40 since college, and increasingly, I find myself crossing my fingers that it will last just a little bit longer. This cold morning, it pauses for an especially long time — long enough that I start to think it has reached its last straw when, in one last gasp, the engine finally catches and settles into a low thrum.

Dec 18, 2023 | opmed.doximity.com | Lynne Lederman |Neelaysh Vukkadala |Danielle Pigneri

Jack Cuzick, PhD, discussed recent progress in breast cancer (BC) prevention in his McGuire Award Lecture at SABCS. “If there was ever a cancer that needed work on prevention, it’s breast cancer,” he said, noting that this most common cancer in women is increasing in incidence worldwide. A risk-adaptive approach to prevention should include identifying those at high risk as well as developing effective, minimally toxic prophylaxis.

Dec 18, 2023 | opmed.doximity.com | Lynne Lederman |Neelaysh Vukkadala |Danielle Pigneri

Practice-Changing Presentations Added to SABCS General SessionSibylle Loibl, MD presented the final analysis of invasive disease-free survival (IDFS) and overall survival (OS) outcomes from the phase 3 KATHERINE trial of adjuvant ado-trastuzumab emtansine (T-DM1) versus trastuzumab for residual invasive HER2+ early breast cancer (BC) after ≥6 cycles of neoadjuvant chemotherapy and ≥9 cycles of trastuzumab.